The data for the ticker SAIC is limited.
| Field | Value (USD) |
|---|---|
| Gross Profit | $892M |
| Total Revenue | $7.5B |
| Cost Of Revenue | $6.6B |
| Costof Goods And Services Sold | $6.6B |
| Operating Income | $563M |
| Selling General And Administrative | $339M |
| Research And Development | - |
| Operating Expenses | $329M |
| Investment Income Net | - |
| Net Interest Income | -$126M |
| Interest Income | - |
| Interest Expense | $126M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $140M |
| Income Before Tax | $428M |
| Income Tax Expense | $66M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $362M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $554M |
| Ebitda | $694M |
| Net Income | $362M |
| Field | Value (USD) |
|---|---|
| Total Assets | $5.2B |
| Total Current Assets | $1.2B |
| Cash And Cash Equivalents At Carrying Value | $56M |
| Cash And Short Term Investments | $56M |
| Inventory | - |
| Current Net Receivables | $1B |
| Total Non Current Assets | $4.1B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $779M |
| Intangible Assets Excluding Goodwill | $779M |
| Goodwill | $2.9B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $98M |
| Other Non Current Assets | - |
| Total Liabilities | $3.7B |
| Total Current Liabilities | $1.4B |
| Current Accounts Payable | $631M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $313M |
| Total Non Current Liabilities | $2.3B |
| Capital Lease Obligations | $173M |
| Long Term Debt | $1.9B |
| Current Long Term Debt | $313M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $2.4B |
| Other Current Liabilities | $452M |
| Other Non Current Liabilities | $169M |
| Total Shareholder Equity | $1.6B |
| Treasury Stock | - |
| Retained Earnings | $1.6B |
| Common Stock | - |
| Common Stock Shares Outstanding | $51M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $494M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $140M |
| Capital Expenditures | $36M |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | -$35M |
| Cashflow From Financing | -$498M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $75M |
| Dividend Payout Common Stock | $75M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$558M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $362M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $892M |
| Total Revenue | $7.5B |
| Cost Of Revenue | $6.6B |
| Costof Goods And Services Sold | $6.6B |
| Operating Income | $563M |
| Selling General And Administrative | $339M |
| Research And Development | - |
| Operating Expenses | $329M |
| Investment Income Net | - |
| Net Interest Income | -$126M |
| Interest Income | - |
| Interest Expense | $126M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $140M |
| Income Before Tax | $428M |
| Income Tax Expense | $66M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $362M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $554M |
| Ebitda | $694M |
| Net Income | $362M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-10-10 |
| Declaration Date | 2025-08-29 |
| Record Date | 2025-10-10 |
| Payment Date | 2025-10-24 |
| Amount | 0.37 |